# FDA recall D-023-2014

> **Hospira, Inc.** · Class II · drug recall initiated 2013-09-16.

## Product

Morphine Sulfate Injection, USP, (25mg/mL), 250 mg, 10mL Fill, Single dosage Flip top Vial, (C-II), (NDC 0409-1135-02), Rx Only, Manfactured for Hospira, Inc., Lake Forest, IL 60045 USA.

## Reason for recall

Lack of Assurance of Sterility: Confirmed customer report of leakage of vial contents due to the breaking of the vial neck.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-023-2014
- **Recalling firm:** Hospira, Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-09-16
- **Report date:** 2013-12-11
- **Termination date:** 2014-10-28

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Lake Forest, IL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-023-2014

## Citation

> AI Analytics. FDA recall D-023-2014. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-023-2014. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*